Metoprolol Succinate
These highlights do not include all the information needed to use metoprolol succinate extended-release tablets safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. METOPROLOL succinate extended-release tablets USP, for oral useInitial U.S. Approval: 1992
6cfe96df-bd75-432d-b2c2-e26143ca36dd
HUMAN PRESCRIPTION DRUG LABEL
Apr 26, 2022
Oryza Pharmaceuticals, Inc
DUNS: 080337493
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Metoprolol Succinate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
Metoprolol Succinate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
Metoprolol Succinate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
Metoprolol Succinate
Product Details
FDA regulatory identification and product classification information